Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...
The Dell Inspiron 15 has some fairly robust specs. At its heart, the Intel i5-1235U processor with 10 cores and up to 4.40 ...
Better book a session with your therapist — yet another painful consequence of your parents’ divorce has emerged.
Inquirer on MSN2d
Controlled drug Ketamine a lifeline for patients with severe depression in S’poreKetamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
Get your itchy fingers ready — Samsung’s Galaxy Unpacked event is today at 1pm Eastern, which means the long-awaited ...
19h
California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback